The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of comprehensive genomic profiling (CGP) on physician treatment recommendations in metastatic solid tumor pts who previously failed at least two standard therapies: A prospective study.
 
Stuart P. Leitner
Stock and Other Ownership Interests - Alnylam; Amgen; Bristol-Myers Squibb; Foundation Medicine; Genomic Health; Halozyme; Incyte; Pfizer; Tekmira
 
Andrew Bennett Brown
Honoraria - Boehringer Ingelheim; Myriad Genetics
Consulting or Advisory Role - Boehringer Ingelheim; Myriad Genetics
Speakers' Bureau - Boehringer Ingelheim; Myriad Genetics
Travel, Accommodations, Expenses - Boehringer Ingelheim; Myriad Genetics
 
Miguel Conde
Stock and Other Ownership Interests - Gilead Sciences; Juno Therapeutics; Pharmacyclics
Consulting or Advisory Role - Janssen Biotech
 
I. Robert Grossman
No Relationships to Disclose
 
Richard Alan Michaelson
Honoraria - Celgene; Novartis
Consulting or Advisory Role - Celgene; Novartis; Roche Pharma AG
Speakers' Bureau - Novartis
 
Delia Radovich
No Relationships to Disclose
 
Michael Scoppetuolo
No Relationships to Disclose
 
Jennifer A. Wagmiller
No Relationships to Disclose
 
Norma Alonzo Palma
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Patricia C. Layton
Stock and Other Ownership Interests - Johnson & Johnson